LTR Pharma Limited (ASX:LTP)
Australia · Delayed Price · Currency is AUD 0.4650
+0.0150 (3.33%)
At close: Jul 31, 2026
LTR Pharma Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Net Income | -8.95 | -5.59 | -6.95 | -1.45 | -1.03 | -0.04 |
Depreciation & Amortization | 0 | 0 | - | - | - | - |
Loss (Gain) on Equity Investments | 0.06 | 0.06 | - | - | - | - |
Stock-Based Compensation | 0.8 | 0.8 | 1.3 | 0.02 | - | - |
Other Operating Activities | 0.86 | 0.02 | 0.01 | 0.02 | 0.01 | - |
Change in Accounts Receivable | 0.02 | 0.02 | 0.1 | -0.03 | -0.01 | -0 |
Change in Inventory | -0.02 | -0.02 | - | - | - | - |
Change in Accounts Payable | 0.27 | 0.27 | 0.44 | -0.09 | 0.46 | 0.01 |
Operating Cash Flow | -6.96 | -4.44 | -5.09 | -1.54 | -0.57 | -0.03 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Capital Expenditures | -0 | -0.01 | -0 | -0 | - | - |
Investment in Securities | -1.26 | -0.18 | - | - | - | - |
Investing Cash Flow | -1.27 | -0.19 | -0 | -0 | - | - |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Short-Term Debt Issued | - | - | - | - | - | 0.35 |
Total Debt Issued | - | - | - | - | - | 0.35 |
Net Debt Issued (Repaid) | - | - | - | - | - | 0.35 |
Issuance of Common Stock | - | 35.5 | 7 | 1.45 | 2.34 | 0.1 |
Other Financing Activities | - | -2.13 | -0.5 | -0.07 | - | -0.27 |
Financing Cash Flow | - | 33.37 | 6.5 | 1.38 | 2.34 | 0.18 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Foreign Exchange Rate Adjustments | -0.06 | -0.03 | -0.03 | -0.02 | -0.01 | -0 |
Net Cash Flow | -8.29 | 28.71 | 1.37 | -0.18 | 1.76 | 0.15 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Free Cash Flow | -6.96 | -4.45 | -5.09 | -1.54 | -0.57 | -0.03 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -615.44% | -294.96% | -10396.58% | - | -6258.86% | - |
Free Cash Flow Per Share | -0.04 | -0.03 | -0.04 | -0.01 | - | - |
Levered Free Cash Flow | -4.47 | -2.75 | -2.83 | -1.35 | -0.31 | - |
Unlevered Free Cash Flow | -4.47 | -2.75 | -2.83 | -1.35 | -0.31 | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash Interest Paid | 0 | 0 | 0 | 0 | 0 | - |
Cash Income Tax Paid | - | - | - | - | -0.01 | - |
Change in Working Capital | 0.27 | 0.27 | 0.54 | -0.12 | 0.45 | 0.01 |